1.Maternal diet on neonatal inpact of gestational diabetes mellitus
Chinese Journal of Primary Medicine and Pharmacy 2011;18(19):2617-2618
ObjectiveTo study the maternal diet on neonatal weight and gestational diabetes,placental function and the impact of it. Methods93 cases of maternal gestational diabetes admitted to hospital with informed consent according to odd and even numbers randomly divided to observation group(50 case) and control group(43 cases) ,all accept conventional treatment,including exercise,health education and drug,observation group plus with diet control,compare the two sets of maternal placental maturity,amniotic fluid situation and the situation of fetal weight. ResultsObservation group with normal weight was 38 cases(76.0% ) ,low body weight was 9 cases( 18.0% ) ,huge children was 3 cases(6.0% ) ,control group was 27 cases( 62.8% ) ,2 cases(4.7% ), 14 cases( 32.6% ) ,two groups of great children birth rate had no significant difference( x2 =9.210,P =0. 002) ;placental maturity between the two groups showed no significant differenee( x2 =1. 034,3. 353 and 0. 433,P =0. 307,0. 067and 0. 510). Observation group normal amniotic fluid was 42 cases(84.0% ) ,oligohydranmios was 6 cases( 12.0% ) ,polyhydramnios was 2 cases(4.0% ) ,the control group was 28 cases(65.1% ) ,3 cases(7.0% ) ,12 cases(27.9% ) ,normal amniotic fluid and polyhydranmnios were significant differences between the two groups ( x2 =4. 429,8. 548, P =0. 035,0. 003 ).ConclusionDiet can reduce fetal macrosomia and the incidence of oligohydramnios, and it could ensure the maternal and child safety.
2.Clinical Study onXiaozhikang Formula Granules for the Treatment of Nonalcoholic Fatty Liver Disease
Chinese Journal of Information on Traditional Chinese Medicine 2015;22(8):22-25
Objective To observe the clinical efficacy ofXiaozhikang Formula Granules for the treatment of nonalcoholic fatty liver disease.Methods Totally 90 patients with nonalcoholic fatty liver disease were randomly divided into control group and treatment group, 45 cases in each group. Patients in the control group were treated with conventional western treatment and oral metformin enteric-coated metformin hydrochloride, while patients in the treatment group were treated withXiaozhikang Formula Granules on the basis of conventional western treatment for 3 months. Blood lipid and insulin resistance in the two groups before and after treatment were observed, and the clinical efficacy between the two groups was compared.Results Clinical excellence (35.5%), total effective rate (84.5%) and TCM syndrome score (13.78 ± 3.6) after treatment of treatment group were better than those of control group (P<0.05). GPT, GOT, TG, and TC in both groups were lower after the treatment (P<0.05,P<0.01). There existed statistical significance in TC and TG between the two groups after treatment (P<0.05). There existed statistical significance in B ultrasound index between the two groups after treatment (P<0.05), and the treatment group was superior. FBG and HOMA-IR in both groups significantly decreased after treatment (P<0.05), and the FBG in the treatment group after treatment was better than control group (P<0.05).Conclusion The efficacy ofXiaozhikang Formula Granules in the treatment of nonalcoholic fatty liver disease is remarkable.
3.Clinical Observation of Shenqiluotong Capsule on 100 Patients with Diabetes Mellitus Crura Angiopathy
Hongwei ZHAI ; Yucheng XU ; Dujin WANG
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(06):-
Objective To observe the clinical effect of Shenqiluotong capsule on diabetes mellitus crura angiopathy.Methods Two hundred patients with diabetes mellitus crura angiopathy were randomly divided into two groups.One hundred patients in the treatment group were administrated Shenqiluotong capsule and enteric-coated aspirin tablet orally.One hundred patients in the control group were only given enteric-coated aspirin tablet orally.The effectiveness,clinical symptom and sign,glucose,blood fat,hemodynamics,crura artery diameter,peak value rate,blood flow volume and side effect were observed before and after treatment.Results The total effective rate in the treatment group and the control group were 89 % and 71% respectively(P
4.Dual-source CT angiography for evaluation of coronary artery stenosis in elderly and middle-agedpatients
Bin QIAN ; Hongwei CHEN ; Liyuan WU ; Yin CHEN ; Xiaodong ZHAI
Chinese Journal of General Practitioners 2012;11(1):51-53
One hundred patients were diagnosed with coronary heart disease through dual-source CT coronary angiography (DSCTA) in our hospital,including 53 cases aged ≥60 y (elderly group) and 47 cases <60 y (middle-aged group).The curved-planar reconstruction (CPR),maximal intensity projection (MIP) and other post-processing reconstruction techniques were used to evaluate the indicators and differences of coronary stenosis ≥ 50% ; the X-ray coronary angiography (CAG) findings were regarded as the gold standard.The evaluable rates of coronary arteries through DSCTA were 97.0% and 98.6% for two groups (P >0.05).The positive rate of coronary artery stenosis ≥ 50% in elderly group was higher than that of middle-age group ( 12.6% vs 9.0% P <0.05 ).The rates of multi-vessel disease in elderly group (28.3% ) was also significantly higher than that of middle-age group (6.4%,P <0.05 ).The sensitivity,specificity,positive predictive value and negative predictive value in evaluation of coronary artery stenosis ≥ 50% for elderly patients were 92.3%,98.0%,88.0% and 98.9% respectively; those for middle-aged patients were 96.0%,99.0%,90.6% and 99.6% respectively ( P >0.05 ).DSCTA imaging provides an effective screening and evaluation method for coronary heart disease in elderly and middle-aged patients.
5.Early Rehabilitation on Function Recovery in Stroke Patients
Zunke GONG ; Hongwei ZHAI ; Wei CHEN ; Zhigang WEI ; Haiyun SUN
Chinese Journal of Rehabilitation Theory and Practice 2009;15(6):571-573
Objective To explore the effect of early rehabilitation on function recovery in stroke patients.Methods 70 patients were divided into two groups, rehabilitation group (38 cases) and control group (32 cases). Rehabilitation group was given clinical treatment and early rehabilitatio therapy, while control group was given clinical treatment and unguided self-training, and the evaluation was done in pre-treatment and eight weeks after the treatment respectively. Motor function of limbs was assessed in Brunnstrom grade and Fugl-Meyer Assessment (FMA), Neurological Function would be assessed with the scale of Clinical Neurological Function Defects (CNFD), and Activities of Daily Living was assessed in Modified Barthel Index(MBI). Results All scores in the rehabilitation group were superior to that in the control group (P< 0.05). Conclusion Early rehabilitation training on stroke patients may obviously improve motor function, promote neurological function and increasing the activities of daily living.
6.Effects of Proprioception Strengthening Training on Knee Osteoarthritis
Zunke GONG ; Hongwei ZHAI ; Wei CHEN ; Jie SUN ; Haiyan WANG
Chinese Journal of Rehabilitation Theory and Practice 2010;16(2):158-160
ObjectiveTo observe the therapeutic effect of proprioception strengthening training on knee osteoarthritis.MethodsBased on clinical diagnostic criteria, 80 patients with knee osteoarthritis were randomly divided into a treatment group(41 cases) and a control group(39 cases). The patients in the treatment group were administered proprioception strengthening training, muscle strengthening exercise and treatment with sodium hyaluronate injection of knee joint, while the patients in the control group were administered muscle strengthening exercise and treatment with sodium hyaluronate injection of knee joint. Before and after the treatment, knee function were assessed with Lysholm Assessment Standard on knee function.ResultsThe patients in both groups scored significantly higher on Lysholm on knee function than the patients before the treatment (P<0.01). The patients in the treatment group are better than the patients in the control group(P<0.01).ConclusionProprioception strengthening training can improve the knee function and it is a valid method to treat knee osteoarthritis.
7.Effect of Marine Capsules on BALB/c Human Hepatocellular Carcinoma Cell Line SMMC-7721 in vitro
Lu LU ; Jinghui ZHAI ; Hongwei ZHAO
China Pharmacist 2017;20(12):2104-2106
Objective:To observe the effect of marine capsules on BALB/c human hepatocellular carcinoma cell line SMMC-7721 in vitro. Methods:Human hepatoma SMMC-7721 cell line was cultured in vitro to establish a hepatoma tumor model, and was random-ly divided into the model control group, 5-Fu group (25 mg·kg-1), marine capsules high dose group (90 mg·kg-1), marine cap-sules low dose group (45 mg·kg-1 ) and the blank control group with 10 mice in each and 14-day continuous administration. Blood was taken from the eyeball and serum was isolated. The tumor strains were picked, the wet weight was obtained, the inhibition rate was calculated, and the pathological changes of tumor tissues were observed after HE staining. Results: Compared with that in the model control group, the serum IL-2 content significantly increased in the marine capsules high and the low dose groups ( P<0. 01, P<0. 05). The in vitro growth of tumor (P<0. 001, P<0. 05) was inhibited with the inhibition rate of 41. 56% and 27. 78% respectively for the high dose group and the low dose group, and the effects of the high dose group had no significant differences with those of 5-Fu group (P>0. 05). The nuclear staining of tumor cells was lighter and the number of tumor cells decreased in the two marine capsules groups. Conclusion:Marine capsules have certain inhibitory effects on BALB/c human hepatocellular carcinoma cell line SMMC-7721 in vitro.
8.Effect of timing of immune checkpoint inhibitor monotherapy and application of hormone on the efficacy and safety of brain metastasis in advanced non-small cell lung cancer: a Meta-analysis
Binbin SHAN ; Jinfang ZHAI ; Hongwei LI ; Xiaoqin AN ; Chang ZHAO ; Qiao HAN ; Yuan LI ; Weihua YANG
Cancer Research and Clinic 2022;34(7):529-536
Objective:To evaluate the efficacy and safety of programmed death 1 (PD-1), programmed death ligand 1 (PD-L1) immune checkpoint inhibitor (ICI) monotherapy for brain metastasis in advanced non-small cell lung cancer (NSCLC), and to explore the timing of immunomonotherapy and the application of hormone on the efficacy of ICI.Methods:By searching literature in CNKI, Wanfang, VIP, PubMed, CBM, Embase, Cochrane Library and Web of Science databases, the advanced NSCLC patients with brain metastasis who received ICI treatment were identified, including patients with symptomatic brain metastasis who had received hormone therapy or brain surgery or radiotherapy. Meta-analysis was performed on the collected data to evaluate the systemic objective response rate (sORR) and intracerebral tumor objective response rate (iORR), the iORR of whether ICI monotherapy was first-line therapy, and the iORR of whether hormone was used were evaluated, and the incidence of adverse reactions was evaluated.Results:Fifteen studies were finally included, with a total of 4 033 patients, including 917 patients with brain metastasis. The iORR of immunomonotherapy was 26% (95% CI 19%-34%) and the sORR was 28% (95% CI 18%-40%). The iORR of first-line immunomonotherapy was 49% (95% CI 39%-58%). The iORR of symptomatic patients with hormone therapy and asymptomatic patients without hormone therapy was 26% (95% CI 20%-33%) and 19% (95% CI 16%-22%), respectively. The overall incidence of grade 3-4 adverse reactions was 14% (95% CI 11%-17%). Conclusions:The efficacy of ICI monotherapy in the first-line treatment of PD-L1-positive NSCLC patients with brain metastasis is better than that in the subsequent line therapy, and the application of hormone does not affect the efficacy of ICI. ICI monotherapy in the treatment of advanced NSCLC patients with brain metastasis is safe.